Biotech Stocks Surge to New 52-Week Highs

Several biotechnology stocks hit 52-week highs on September 8, 2026, fueled by promising clinical developments and key regulatory milestones. Pharvaris N.V. jumped seven percent, Roivant Sciences climbed six percent following positive trial readouts, and Bellicum Pharmaceuticals gained four percent. Additional gains were recorded across the sector as investors responded enthusiastically to ongoing biopharmaceutical advancements and expanding late-stage clinical pipelines.